1.48 USD
▲+0.03+2.78%
盘后 1.46 +1.33%
2026-08-03
市值
$228.29M
市盈率
1.23
EPS
1.52
股息率
—
52 周区间
0.81 – 2.62
成交量
617.72K
Beta
0.98
目标价
7.80
52W 低 0.8152W 高 2.62
价格走势
公司简介
Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor; LOQTORZI, a novel next-generation programmed death receptor-1 inhibitor; and Casdozokitug, an investigational recombinant human immunoglobulin isotype (IgG1) monoclonal antibody targeting interleukin IL-27. It also develops CHS-114, an investigational human afucosylated IgG1 monoclonal antibo...